Literature DB >> 10869331

Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China.

C Dye1, Z Fengzeng, S Scheele, B Williams.   

Abstract

BACKGROUND: Tuberculosis (TB) is still amongst the most important causes of human morbidity and mortality, killing approximately two million people each year. Standard short-course chemotherapy (SSCC) can rapidly control illness and dramatically reduce the chance of death, but the impact of treatment has rarely been evaluated in these terms.
METHOD: We developed a mathematical model that makes use of routinely-collected data to calculate the number of deaths directly prevented by TB treatment (i.e. excluding those due to reduced transmission). The method was applied to the world's largest TB control programme covering over 500 million people in 12 provinces of China.
RESULTS: Counties which had been enrolled in the programme since 1991 were, by 1997, preventing at least 46% (37-56%) of the TB deaths that would otherwise have occurred. If replicated across the entire TB control programme area, this would amount to 30 000 (range 26 000-59 000) deaths directly prevented each year.
CONCLUSIONS: Short-course chemotherapy has substantially reduced TB mortality in half of China. The analytical method described here could be applied to TB control operations in many other countries, and should help to quantify the true burden of tuberculosis alleviated by SSCC.

Entities:  

Keywords:  Asia; China; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Epidemiology; Health; Infections; Mathematical Model; Models, Theoretical; Mortality--prevention and control; Organization And Administration; Population; Population Dynamics; Program Evaluation; Programs; Public Health; Research Methodology; Research Report; Treatment; Tuberculosis--prevention and control

Mesh:

Substances:

Year:  2000        PMID: 10869331

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  12 in total

1.  Treatment outcomes of pulmonary tuberculosis in the past decade in the mainland of China: a meta-analysis.

Authors:  Xiangwei Li; Yu Yang; Jianmin Liu; Feng Zhou; Wei Cui; Ling Guan; Fei Shen; Cong Gao; Mufei Li; Qi Jin; Lei Gao
Journal:  Front Med       Date:  2013-07-11       Impact factor: 4.592

2.  Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics.

Authors:  Reza Yaesoubi; Ted Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

Review 3.  Rethinking prevention of HIV type 1 infection.

Authors:  David N Burns; Carl W Dieffenbach; Sten H Vermund
Journal:  Clin Infect Dis       Date:  2010-09-15       Impact factor: 9.079

4.  A chain-binomial model for intra-household spread of Mycobacterium tuberculosis in a low socio-economic setting in Pakistan.

Authors:  S Akhtar; T E Carpenter; S K Rathi
Journal:  Epidemiol Infect       Date:  2006-06-02       Impact factor: 2.451

5.  Lives saved by Global Fund-supported HIV/AIDS, tuberculosis and malaria programs: estimation approach and results between 2003 and end-2007.

Authors:  Ryuichi Komatsu; Eline L Korenromp; Daniel Low-Beer; Catherine Watt; Christopher Dye; Richard W Steketee; Bernard L Nahlen; Rob Lyerla; Jesus M Garcia-Calleja; John Cutler; Bernhard Schwartländer
Journal:  BMC Infect Dis       Date:  2010-04-30       Impact factor: 3.090

6.  Heightened vulnerability to MDR-TB epidemics after controlling drug-susceptible TB.

Authors:  Jason D Bishai; William R Bishai; David M Bishai
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

7.  Combining domestic and foreign investment to expand tuberculosis control in China.

Authors:  Zhong-wei Jia; Shi-ming Cheng; Zhi-jun Li; Xin Du; Fei Huang; Xiao-wei Jia; Peng Kong; Yun-xi Liu; Wei Chen; Wei Wang; Christopher Dye
Journal:  PLoS Med       Date:  2010-11-23       Impact factor: 11.069

8.  Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2017-05-18       Impact factor: 79.321

Review 9.  Global epidemiology of tuberculosis.

Authors:  Philippe Glaziou; Charalambos Sismanidis; Katherine Floyd; Mario Raviglione
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-30       Impact factor: 6.915

10.  Antiretroviral therapy outcomes in HIV-infected children after adjusting protease inhibitor dosing during tuberculosis treatment.

Authors:  Cordula Frohoff; Magendhree Moodley; Lee Fairlie; Ashraf Coovadia; Harry Moultrie; Louise Kuhn; Tammy Meyers
Journal:  PLoS One       Date:  2011-02-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.